Ghoul
Member
5% of US adults have this (fibrosing fatty liver), and now qualify for Wegovy if their insurance covers it (most do). In the later stages of fatty liver tissue starts to get fibrotic, just before permanent scarring (cirrhosis). Fatty liver is becoming very common (30% of adults), but often undiagnosed:
www.prnewswire.com
Wegovy® approved by FDA for the treatment of adults with noncirrhotic MASH with moderate to advanced liver fibrosis
Wegovy® (semaglutide) injection 2.4 mg is now indicated to treat adults with metabolic dysfunction-associated steatohepatitis (MASH) with moderate to advanced...
